Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06162221
Title Study of RAS(ON) Inhibitor Combinations in Patients With Advanced RAS-mutated NSCLC
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Revolution Medicines, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ITA | FRA | ESP | DEU

Additional content available in CKB BOOST